Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/43041
DC FieldValueLanguage
dc.contributor.authorNaranjo, Antonio
dc.contributor.authorOjeda-Bruno, Soledad
dc.contributor.authorBilbao Cantarero, Ana
dc.contributor.authorQuevedo Abeledo, Juan Carlos
dc.contributor.authorHenríquez-Hernández, Luis Alberto
dc.contributor.authorRodríguez-Lozano, Carlos
dc.contributor.otherNaranjo Hernandez, Antonio
dc.contributor.otherHenriquez-Hernandez, Luis Alberto
dc.date.accessioned2018-11-21T12:13:22Z-
dc.date.available2018-11-21T12:13:22Z-
dc.date.issued2014
dc.identifier.issn1699-258X
dc.identifier.urihttp://hdl.handle.net/10553/43041-
dc.description.abstractObjective: To assess the influence of the implementation of a program for secondary prevention of osteoporotic fractures on prescribing bisphosphonates and persistent short-term treatment. Patients and methods: Patients >. 50 years with fragility fracture attended in the emergency department were enrolled in an observational study. The program consisted of: 1) training of primary care physicians, 2) baseline visit: questionnaire on osteoporosis, bone densitometry and patient education, 3) patient referral to primary care, except those with multiple fractures or requiring special study or therapy, who were referred to a specialist, and 4) follow-up by checking prescriptions in electronic records, and a telephone survey. The outcome variable was the percentage of patients who, on having been prescribed bisphosphonates, still adhered to the treatment at 3 months. Results: Of the 532 patients with inclusion criteria, 202 (39%) refused to participate. Those who refused to take part had a higher mean age (P<. .01) and a higher frequency of hip fracture (P<. .01) compared with patients who did participate. A total of 330 patients were included for intervention, with a mean age of 71 years, and 254(77%) were female. An antiresorptive was being used by 45 patients (13%) at baseline. After the baseline visit 223 patients (67%) were recommended a bisphosphonate. In the follow-up at 3 months 78% of patients who had been prescribed bisphosphonate were still receiving treatment. Conclusions: We present a multidisciplinary program for secondary prevention of fractures coordinated by rheumatology in which the number of patients who were receiving bisphosphonate at 3 months increased by four times compared to baseline visit. © 2013 Elsevier España, S.L.U.
dc.publisher1699-258X
dc.relation.ispartofReumatologia Clinica
dc.sourceReumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303
dc.titleResults of a model of secondary prevention for osteoporotic fracture coordinated by rheumatology and focused on the nurse and primary care physicians
dc.typeinfo:eu-repo/semantics/Articlees
dc.typeArticlees
dc.identifier.doi10.1016/j.reuma.2013.12.007
dc.identifier.scopus84906790010-
dc.identifier.isi000421428100006
dcterms.isPartOfReumatologia Clinica
dcterms.sourceReumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303
dc.contributor.authorscopusid7003297397
dc.contributor.authorscopusid6602428868
dc.contributor.authorscopusid7801311085
dc.contributor.authorscopusid55295814500
dc.contributor.authorscopusid15829708200
dc.contributor.authorscopusid6603136298
dc.description.lastpage303
dc.description.firstpage299
dc.relation.volume10
dc.type2Artículoes
dc.identifier.wosWOS:000421428100006
dc.contributor.daisngid550893
dc.contributor.daisngid4801071
dc.contributor.daisngid8143522
dc.contributor.daisngid7862165
dc.contributor.daisngid465624
dc.contributor.daisngid1048977
dc.identifier.investigatorRIDE-7910-2010
dc.identifier.investigatorRIDNo ID
dc.date.coverdateEnero 2014
dc.identifier.ulpgces
dc.description.esciESCI
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Grupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptGIR IUIBS: Medio Ambiente y Salud-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0002-2013-6664-
crisitem.author.orcid0000-0003-3237-0316-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameNaranjo Hernández, Antonio-
crisitem.author.fullNameHenríquez Hernández, Luis Alberto-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

21
checked on Nov 17, 2024

WEB OF SCIENCETM
Citations

22
checked on Nov 17, 2024

Page view(s)

31
checked on Jul 8, 2023

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.